Phase I study for high dose hypofractionated radiotherapy in early stage glottic cancer

Phase I study for evaluation of the safety of high dose hypofractionated radiotherapy in early stage glottic cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CRIS

Registry ID

KCT0001805

Enrollment

Registered

2016-02-05

Start date

2015-05-15

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Radiation : Group 1: 3.5 Gy x 17 fractions Group 2: 5 Gy x 11 fractions Group 3: 9 Gy x 5 fractions

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A. Age: 20 years or older. B. Histologically confirmed squamous cell carcinoma in vocal cords C. Clinical stage T1-2N0M0 D. Performance status: ECOG 0-2, KPS 50-100 E. Decided to participate in this clinical trial voluntarily, and signed the written informed consent

Exclusion criteria

Exclusion criteria: A. Prior neck radiotherapy B. Palliative aim C. Involved in posterior commissure

Design outcomes

Primary

Measure	Time frame
Toxicity	—

Secondary

Measure	Time frame
Quality of life;Tumor response	—

Countries

Korea, Republic of

Contacts

Public ContactTosol Yu

Seoul National University Hospital

tosolyu@naver.com

Outcome results